Detalhe da pesquisa
1.
Clinical Investigation of Metabolic and Renal Clearance Pathways Contributing to the Elimination of Fevipiprant Using Probenecid as Perpetrator.
Drug Metab Dispos
; 49(5): 389-394, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33632715
2.
On the optimal temporal resolution for phase contrast cardiovascular magnetic resonance imaging: establishment of baseline values.
J Cardiovasc Magn Reson
; 22(1): 72, 2020 10 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33012283
3.
Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide.
Br J Clin Pharmacol
; 84(5): 926-936, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29318651
4.
Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects.
Eur J Clin Pharmacol
; 74(9): 1121-1130, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-29974143
5.
The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
Eur Heart J
; 38(44): 3308-3317, 2017 Nov 21.
Artigo
Inglês
| MEDLINE | ID: mdl-29029087
6.
Pharmacokinetics and safety of sacubitril/valsartan (LCZ696) in patients with mild and moderate hepatic impairmentâ©.
Int J Clin Pharmacol Ther
; 55(9): 728-739, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28737127
7.
The effect of LCZ696 (sacubitril/valsartan) on amyloid-ß concentrations in cerebrospinal fluid in healthy subjects.
Br J Clin Pharmacol
; 81(5): 878-90, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26663387
8.
Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization.
Eur J Clin Pharmacol
; 72(8): 917-24, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27083930
9.
Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor.
Eur J Clin Pharmacol
; 72(9): 1065-73, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27230850
10.
Effect of food on the oral bioavailability of the angiotensin receptor - neprilysin inhibitor sacubitril/valsartan (LCZ696) in healthy subjectsâ©.
Int J Clin Pharmacol Ther
; 54(12): 1012-1018, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27719743
11.
Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
Arch Dis Child
; 108(9): 730-735, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36963813
12.
Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.
Am J Respir Cell Mol Biol
; 45(1): 62-71, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20813993
13.
KIS protects against adverse vascular remodeling by opposing stathmin-mediated VSMC migration in mice.
J Clin Invest
; 118(12): 3848-59, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19033656
14.
Variability of MRI Aortic Stiffness Measurements in a Multicenter Clinical Trial Setting: Intraobserver, Interobserver, and Intracenter Variability of Pulse Wave Velocity and Aortic Strain Measurement.
Radiol Cardiothorac Imaging
; 2(2): e190090, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33778551
15.
GA-binding protein regulates KIS gene expression, cell migration, and cell cycle progression.
FASEB J
; 22(1): 225-35, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17726090
16.
Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.
J Mol Med (Berl)
; 85(8): 797-810, 2007 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-17429599
17.
Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?
Clin Pharmacol Ther
; 103(5): 802-814, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29315510
18.
Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.
Clin Pharmacokinet
; 57(1): 105-123, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28527109
19.
Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension.
Hypertension
; 71(1): 70-77, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29180454
20.
Pharmacokinetics After Single Ascending Dose, Food Effect, and Safety of Sacubitril/Valsartan (LCZ696), an Angiotensin Receptor and Neprilysin Inhibitor, in Healthy Japanese Subjects.
Eur J Drug Metab Pharmacokinet
; 42(3): 407-416, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27324506